Replies to post #30293 on Biotech Values

[DewDiligence]

> MATK – “we expect that the scope of product launches will be limited at first, targeting customers at high-end stores or health food oriented stores, who are the more likely purchasers.”<

Thanks for posting that. I’ll keep my eye out for these products at Whole Foods. The store manager at my local store is a chatty fellow who doesn’t mind spilling the beans (or the yogurt) in reply to questions about how specific products are moving. Regards, Dew

p.s. ML’s new report on MATK sounds like something I might have written a year ago about SNMX.

[DewDiligence]

MATK – DHA/ARA-enhanced infant formula has an 85% market share of all infant formula in the U.S. and a 30% share in the rest of the world.

A small number of formula companies outside the U.S. are blending DHA from fish oil with MATK’s ARA. This could become a troubling trend, IMO.

Food sales of DHA are still tiny: about $500K in the most recent quarter. MATK has been saying for years that this market was on the verge of exploding; will 2007 be the year when it finally happens?

(Source: Today’s MATK CC)

p.s. MATK is down 16% in AH trading.